Testing the Combination of Copanlisib, Nivolumab and Ipilimumab in Patients With Advanced Cancer and Lymphoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Chinese PLA General Hospital
Chinook Therapeutics, Inc.
National Institutes of Health Clinical Center (CC)
Lytix Biopharma AS
National Institutes of Health Clinical Center (CC)